Try our Advanced Search for more refined results

Expert Analysis

The Important Reasons DOJ Wants To Toss Gilead FCA Case

By Derek Adams (April 4, 2019, 10:46 AM EDT) -- Last November, the U.S. Department of Justice responded to the U.S. Supreme Court's invitation to file an amicus brief in Gilead Sciences Inc. v. United States ex rel. Jeffrey Campie et al., No. 17-936[1], a qui tam case alleging that Gilead covertly arranged to have key ingredients in certain pharmaceutical drugs produced at two non-U.S. manufacturing facilities with purported problems....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Judge Analytics

powered by Lex Machina®

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!